Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4001
Definitive Healthcare
DH
$69.4M
| $180K | ﹤0.01% |
62,178
-29,134
| -32% | -$118K |
|
4002
Eos Energy Enterprises
EOSE
$1.54B
| $179K | ﹤0.01% |
47,425
-10,953
| -19% | -$53.4K |
|
4003
Lifecore Biomedical
LFCR
$181M
| $179K | ﹤0.01% |
25,454
-8,518
| -25% | -$52.9K |
|
4004
Innovator Uncapped Accelerated US Equity ETF
XUSP
$53.4M
| $179K | ﹤0.01% |
+4,795
| New | +$193K |
|
4005
Innovator US Equity Ultra Buffer ETF July
UJUL
$297M
| $179K | ﹤0.01% |
+5,335
| New | +$185K |
|
|
LAZR
4006
DELISTED
Luminar Technologies
LAZR
| $179K | ﹤0.01% |
33,181
-31,887
| -49% | -$193K |
|
|
XDOC
4007
DELISTED
Innovator US Equity Accelerated ETF October
XDOC
| $179K | ﹤0.01% |
6,108
+6,019
| +6,763% | +$183K |
|
4008
Tilray
TLRY
$637M
| $178K | ﹤0.01% |
27,137
+6,403
| +31% | +$59.3K |
|
4009
Richardson Electronics
RELL
$302M
| $178K | ﹤0.01% |
15,925
-5,986
| -27% | -$77.7K |
|
4010
Quad
QUAD
$507M
| $178K | ﹤0.01% |
32,607
-15,457
| -32% | -$98.2K |
|
4011
Evolution Petroleum
EPM
$134M
| $177K | ﹤0.01% |
34,255
-15,054
| -31% | -$78.5K |
|
4012
FVCBankcorp
FVCB
$337M
| $177K | ﹤0.01% |
16,784
-8,287
| -33% | -$94.8K |
|
|
XOMA
4013
DELISTED
Xoma
XOMA
| $177K | ﹤0.01% |
8,896
-3,888
| -30% | -$93.6K |
|
4014
Itaú Unibanco
ITUB
$81.6B
| $177K | ﹤0.01% |
33,199
-330,513
| -91% | -$1.66M |
|
4015
Candel Therapeutics
CADL
$783M
| $177K | ﹤0.01% |
31,322
-2,995
| -9% | -$24.5K |
|
4016
FT Vest US Equity Moderate Buffer ETF August
GAUG
$293M
| $176K | ﹤0.01% |
5,076
-369
| -7% | -$13.1K |
|
4017
James River Group Holdings
JRVR
$199M
| $176K | ﹤0.01% |
41,958
-18,685
| -31% | -$84.8K |
|
|
FSP
4018
Franklin Street Properties
FSP
$46.3M
| $175K | ﹤0.01% |
98,249
-48,458
| -33% | -$89.3K |
|
4019
CALL
Illumina
ILMN
$29.1B
| $175K | ﹤0.01% |
+2,200
| New | +$238K |
|
4020
RGC Resources
RGCO
$225M
| $174K | ﹤0.01% |
8,340
-4,082
| -33% | -$84.1K |
|
4021
Priority Technology Holdings
PRTH
$427M
| $173K | ﹤0.01% |
25,429
-3,698
| -13% | -$35K |
|
4022
DMC Global
BOOM
$155M
| $173K | ﹤0.01% |
20,568
-9,794
| -32% | -$79.9K |
|
4023
Innovator US Equity Ultra Buffer ETF May
UMAY
$141M
| $173K | ﹤0.01% |
5,164
+2,505
| +94% | +$84.8K |
|
4024
FT Vest US Equity Enhance & Moderate Buffer ETF December
XDEC
$204M
| $173K | ﹤0.01% |
4,698
+547
| +13% | +$20.5K |
|
4025
Omega Flex
OFLX
$304M
| $172K | ﹤0.01% |
4,959
-2,139
| -30% | -$82.9K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.